Japan’s Diabetes Market, 2019 to 2024 - The Market Witnessed a CAGR of 4.4% during 2011-2018, and is Anticipated to Exhibit a CAGR of 3.8% during 2019-2024 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 15, 2019--The “Japan Diabetes Market Report: 2019-2024” report has been added to ResearchAndMarkets.com’s offering.
The Japan diabetes market reached a value of more than US$ 4 Billion in 2018, registering a CAGR of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024.
With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country.
The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.
Breakup by Segment
Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.
The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.
Key Questions Answered
2 Scope and Methodology
2.1 Objectives of the Study
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.3 Diabetes Complications
6 Japan Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Japan Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.5 Value Chain Analysis
7.6 Porter’s Five Forces Analysis
7.7 Market Breakup by Segment
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/tscq34
View source version on businesswire.com:https://www.businesswire.com/news/home/20190415005416/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs,Diabetes Drugs
KEYWORD: ASIA PACIFIC JAPAN
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 04/15/2019 07:54 AM/DISC: 04/15/2019 07:54 AM